AGODECOTT LTD

Company number 13525883 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

AGODECOTT LTD - Analysis Report

Company Number: 13525883

Analysis Date: 2025-07-29 12:50 UTC

Financial Health Assessment for AGODECOTT LTD as at 31 July 2024


1. Financial Health Score: D

Explanation:
AGODECOTT LTD shows signs of financial distress with negative net assets and net current assets, indicating the company is technically insolvent at the reporting date. While still operational and compliant with filings, the balance sheet reveals a fragile financial position that requires urgent attention to restore health.


2. Key Vital Signs

Vital Sign Value (£) Interpretation
Cash at Bank 116 Minimal cash reserves, very low liquidity
Current Liabilities 318 Short-term debts exceed available cash
Net Current Assets -202 Negative working capital indicates liquidity strain
Net Assets (Equity) -202 Shareholders’ funds are negative, insolvency symptom
Share Capital 100 Initial investment remains unchanged
Profit & Loss Reserve -302 Accumulated losses eroded equity
Employee Count 1 (average) Micro-business scale

Additional Notes:

  • Directors’ current accounts (£222) form a significant part of short-term liabilities, implying directors have lent money to the company.
  • The company’s category (private limited, micro/small size) limits external funding options.
  • The company’s principal activity is security dealing on own account, a potentially capital-intensive or volatile sector.

3. Diagnosis: Financial Condition

AGODECOTT LTD exhibits "symptoms of distress" primarily due to persistent accumulated losses reflected in the negative profit and loss reserve (-£302) dragging down shareholders’ funds to -£202. The negative net current assets indicate the company’s short-term obligations exceed its liquid assets, a red flag for cash flow difficulties.

The minimal cash balance (£116) is insufficient to cover creditors (£318), signaling tight liquidity and potential payment difficulties. The director’s current account liability (£222) shows reliance on internal funding, which can sustain operations short-term but is not a long-term solution.

The business is still active, with filings up to date and no signs of insolvency procedures. However, the negative equity means the company is technically insolvent under accounting definitions, which may affect its ability to raise external finance or secure supplier credit.

Overall, the company is in a precarious financial state akin to a patient with a weakened heart—still beating but under strain and at risk of collapse without intervention.


4. Recommendations: Steps to Improve Financial Wellness

  1. Immediate Cash Flow Management:

    • Enhance cash inflows by accelerating receivables or increasing sales if possible.
    • Negotiate extended payment terms with creditors to ease short-term pressure.
  2. Capital Injection or Debt Restructuring:

    • Directors or external investors should consider injecting fresh equity to restore positive net assets.
    • Explore restructuring of director loans or convert them into equity to reduce liabilities.
  3. Cost Control and Operational Efficiency:

    • Review all operational expenses to cut non-essential costs; micro-businesses must operate lean to survive.
    • Consider outsourcing or automating tasks to reduce overhead.
  4. Strategic Review of Business Model:

    • Assess the viability of the current security dealing activities.
    • Explore diversification or pivoting to more profitable or stable revenue streams.
  5. Professional Advisory:

    • Engage a financial advisor or turnaround specialist promptly to develop a recovery plan.
    • Maintain up-to-date and transparent financial records to monitor health regularly.

Medical Analogy Summary

AGODECOTT LTD’s financial health resembles a patient with low blood pressure and weak pulse—current assets and cash flow are insufficient to meet liabilities, indicating liquidity shock. Without timely intervention such as capital infusion (akin to a transfusion) and operational adjustments (lifestyle changes), the company risks further deterioration leading to insolvency.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.